Precision BioSciences operates within the highly innovative and competitive gene-editing and biotechnology sector, competing with numerous clinical-stage firms developing advanced genomic medicines. Its industry peers and competitors include other prominent gene-editing innovators such as CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Beam Therapeutics, and Sangamo Therapeutics, all of which focus on creating novel therapeutic modalities targeting genetic and acquired diseases.